MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Other Accumulated Expenses of $2.6 million for Q4 2025, down 90.69% on a QoQ basis from $28.2 million in Q3 2025, and up 191.25% year-over-year from $903000.0 in Q4 2024.
MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $2.6 million for Q4 2025.
- Quarterly Other Accumulated Expenses rose 191.25% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (up 191.25% YoY) and the FY2025 annual result came in at $2.6 million, up 191.25% from the prior year.
- Other Accumulated Expenses was $2.6 million for Q4 2025 at MeiraGTx Holdings, down from $28.2 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $28.2 million in Q3 2025 and bottomed at $134000.0 in Q2 2021.
- A 5-year average of $2.1 million and a median of $449000.0 in 2021 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 5783.54% in 2025, while the deepest fall reached 84.71% in 2025.
- MeiraGTx Holdings' Other Accumulated Expenses stood at $456000.0 in 2021, then jumped by 104.39% to $932000.0 in 2022, then soared by 37.12% to $1.3 million in 2023, then fell by 29.34% to $903000.0 in 2024, then soared by 191.25% to $2.6 million in 2025.
- Business Quant data shows MGTX's Other Accumulated Expenses at $2.6 million in Q4 2025, $28.2 million in Q3 2025, and $160000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 997.33 Mn | 931.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.63 Mn |
| Sep 30, 2025 | 28.24 Mn |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | 903,000.00 |
| Sep 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 260,000.00 |
| Mar 31, 2023 | 321,000.00 |
| Dec 31, 2022 | 932,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 983,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 456,000.00 |
| Sep 30, 2021 | 328,000.00 |
| Jun 30, 2021 | 134,000.00 |
| Mar 31, 2021 | 442,000.00 |